Overweight and obesity increase the risk for liver cancer in patients with liver cirrhosis and long-term oral supplementation with branched-chain amino acid granules inhibits liver carcinogenesis in heavier patients with liver cirrhosis
スポンサーリンク
概要
- 論文の詳細を見る
- 2006-07-01
著者
-
Ohashi Yasuo
Department of Biostatistics/Epidemiology and Preventive Health Sciences, School of Health Sciences a
-
KUMADA Hiromitsu
Department of Hepatology, Toranomon Hospital
-
MORIWAKI H.
Gifu University School of Medicine
-
Kumada Hiromitsu
冲中記念成人病研究所
-
Kumada Hiromitsu
Department Of Gastroenterology Toranomon Hospital
-
Kumada Hiromitsu
国家公務員共済組合連合会虎の門病院 肝臓科
-
Kumada Hiromitsu
国家公務員共済組合連合会虎の門病院 肝臓内科
-
Sato Shunichi
First Department Of Internal Medicine Iwate Medical University School Of Medicine
-
Sato Shinichiro
岩手医科大学 医学部内科学第一
-
SUZUKI KAZUYUKI
First Department of Internal Medicine, Iwate Medical University
-
NISHIGUCHI Shuhei
Division of Hepatobiliary and Pancreatic Medicine, Department of Internal Medicine, Hyogo College of
-
Matsuo Keitaro
愛知県がんセンター研究所 疫学･予防部
-
Sainokami Shigehiko
岩手医科大学 医学部内科学第一
-
Sainokami Shigehiko
The First Department Of Internal Medicine Iwate Medical University
-
Suzuki Kazuyuki
Division Of Gastroenterology And Hepatology Department Of Internal Medicine Iwate Medical University
-
Suzuki Kazuyuki
岩手医科大学 医学部内科学講座消化器･肝臓内科
-
Sato Shunichi
First Department Of Internal Medicine Iwate Medical University
-
Kato Akinobu
First Department of Internal Medicine, Iwate Medical University
-
Moriwaki H
First Department Of Internal Medicine Gifu University Graduate School Of Medicine
-
Moriwaki Hisataka
岐阜大学 医学部内科学
-
Moriwaki Hisataka
がん･感染症センター都立駒込病院 肝臓内科
-
MORIWAKI Hisataka
Department of Internal Medicine, Gifu University Graduate School of Medicine
-
Noguchi Seiji
Department Of Hepatology Osaka City University Graduate School Of Medicine
-
Miwa Yoshiyuki
Department Of Internal Medicine Gifu University Graduate School Of Medicine
-
Miwa Y
Ube Ind. Ltd Yamaguchi Jpn
-
Miwa Yoshiyuki
First Department Of Internal Medicine Gifu Uiversity School Of Medicine
-
Muto Y
Gifu University
-
Muto Yasutoshi
Gifu University
-
WATANABE Akiharu
Department of Internal Medicine (III), Toyama Medical and Pharmaceutical University School of Medici
-
SATO Shunichi
Iwate Medical University
-
KATO Masahiko
School of Life Studies, Sugiyama Jogakuen University
-
NAKAMURA Teiji
Faculty of Health and Social Work, School of Nutrition and Dietetic, Kanagawa University of Human Se
-
HIGUCHI Kiyohiro
Itoigawa General Hospital
-
Watanabe Akiharu
Department Of Clinical Nutrition Faculty Of Health Science And Technology Kawasaki University Of Med
-
Kato Masahiko
School Of Life Studies Sugiyama Jogakuen University
-
Nishiguchi Shuhei
Division Of Hepatobiliary And Pancreatic Disease Department Of Internal Medicine Hyogo College Of Me
-
Matsuo Keitaro
Division Of Epidemiology And Prevention Aichi Cancer Center
-
Kato Akinobu
First Department Of Internal Medicine Iwate Medical University
-
Kano Mayuko
Medical Student Of Nagoya University School Of Medicine Department Of Preventive Medicine-biostatist
-
Miwa Y
Nagoya Univ.
-
Suzuki Kazuyuki
Department Of Surgery 1 Iwate Medical University
-
Kato Motoichiro
Department Of Neuropsychiatry Tokyo Medical And Dental University Ichikawa General Hospital
-
Kato Akinobu
Internal Medicine I Iwate Medical University School Of Medicine
-
Nakamura Teiji
Faculty Of Health And Social Work School Of Nutrition And Dietetic Kanagawa University Of Human Serv
-
Moriwaki H
Gifu Univ. School Of Medicine Gifu Jpn
-
Moriwaki H.
First Department Of Internal Medicine Gifu University School Of Medicine
-
Matsuo Keitaro
Department Of Epidemiology And Prevention Aichi Cancer Center Research Institute
-
Moriwaki Hisataka
Department Of Gastroenterology And Hematology Division Of Organ Pathobiology Gifu University School
-
Nishiguchi Shuhei
Division Of Hepatobiliary And Pancreatic Medicine Department Of Internal Medicine Hyogo College Of M
-
Ohashi Yasuo
Department Of Biostatistics Epidemiology And Preventive Health Sciences And Nursing University Of To
-
Koga Hiroyuki
Department Of Hepatology Toranomon Hospital
-
Nojiri Shunsuke
Department Of Internal Medicine Hyogo College Of Medicine
-
Ohashi Yasuo
Department Of Biostatistics/epidemiology And Preventive Health Sciences School Of Health Sciences An
-
Ohashi Yasuo
Department Of Biostatistics / Epidemiology And Preventive Health Sciences School Of Health Sciences
-
Suzuki Kazuyuki
First Department Of Internal Medicine Iwate Medical University
-
Sato Shin-ichiro
Department Of Pathology Iwate Medical University School Of Medicine
-
Nishiguchi Shuhei
Division Of Hepatobiliary And Pancreatic Disease Department Of Internal Medicine Hyogo College Of Medicine
-
NAKAMURA Teiji
Faculty of Health & Social Work, School of Nutrition & Dietetics Kanagawa University of Human Services
関連論文
- Serum Total and Non-High-Density Lipoprotein Cholesterol and the Risk Prediction of Cardiovascular Events : – The JALS-ECC –
- Chronic Kidney Disease Japan Cohort (CKD-JAC) Study : Design and Methods
- Guidelines for the antiviral therapy of hepatitis C virus carriers with normal serum aminotransferase based on platelet counts
- Timing of interferon therapy and sources of infection in patients with acute hepatitis C
- Randomized Trial of the Long-term Effects of Pravastatin on Coronary Artery Bypass Grafts : PCAB Study(Enrollment number : 60013)
- Radical prostatectomy and adjuvant endocrine therapy for prostate cancer with or without preoperative androgen deprivation : Five-year results
- Endocrine therapy with or without radical prostatectomy for T1b-T3N0M0 prostate cancer
- Early results of radical prostatectomy and adjuvant endocrine therapy for prostate cancer with or without preoperative androgen deprivation
- Preoperative Endocrine Therapy for Clinical Stage A_2, B, and C Prostate Cancer: An Interim Report on Short-Term Effects
- Estimate Criteria for Efficacy of Treatment in Benign Prostatic Hyperplasia
- Estimate Criteria for Diagonsis and Severity in Benign Prostatic Hyperplasia
- 4 On-going Japanese Clinical Trials for Hypertension II : Seeking for More Effective Pharmacological Treatment(ESC-JCS Joint Symposium (ESC-JCS Joint Symposium) (H) Evidence-Based Medical Treatment of Hypertension,Special Program,The 72nd Annual Scientifi
- The Relationship Between the Effect of Pravastatin and Risk Factors for Coronary Heart Disease in Japanese Patients With Hypercholesterolemia
- Japanese phase II study of ^Y-ibritumomab tiuxetan in patients with relapsed or refractory indolent B-cell lymphoma
- Efficacy of platinum analogue for advanced hepatocellular carcinoma unresponsive to transcatheter arterial chemoembolization with epirubicin
- The Efficacy of Interferon-beta Monotherapy for Elderly Patients with Type C Hepatitis of Genotype 2
- Potential of laparoscopy in chronic liver disease with hepatitis B and C viruses
- Inhibitory effect of branched-chain amino acid granules on progression of compensated liver cirrhosis due to hepatitis C virus
- Hepatocarcinogenesis Following HCV RNA Eradication by Interferon in Chronic Hepatitis Patients
- The Efficacy of Short-Term Interferon-Beta Therapy for Type C Cirrhotic Patients with Genotype 2a and Low Virus Load
- Factors associated with the virological response of lamivudine-resistant hepatitis B virus during combination therapy with adefovir dipivoxil plus lamivudine
- Interferon lowers tumor recurrence rate after surgical resection or ablation of hepatocellular carcinoma : a pilot study of patients with hepatitis B virus-related cirrhosis
- Efficacy of interferon monotherapy in young adult patients with chronic hepatitis C virus infection
- Cost-effectiveness of radiofrequency ablation and surgical therapy for small hepatocellular carcinoma of 3cm or less in diameter
- Adequate timing of ribavirin reduction in patients with hemolysis during combination therapy of interferon and ribavirin for chronic hepatitis C
- Efficacy of lamivudine treatment in Japanese patients with hepatitis B virus-related cirrhosis
- Efficacy of 6-month interferon therapy in chronic hepatitis B virus infection in Japan
- Infection with hepatitis B virus genotype A in Tokyo, Japan during 1976 through 2001
- Interferon monotherapy for patients with chronic hepatitis C and normal serum aminotransferase levels at commencement of treatment
- Factors contributing of ribavirin dose reduction due to anemia during interferon alfa2b and ribavirin combination therapy for chronic hepatitis C
- Peripheral CD8+/CD25+ lymphocytes may be implicated in hepatocellular injuries in patients with acute-onset autoimmune hepatitis
- Hepatocellular carcinoma in noncirrhotic young adult patients with chronic hepatitis B viral infection
- Efficacy of interferon retreatment after relapse for chronic hepatitis C patients with biochemical response after first interferon therapy
- Successful control of ruptured hepatocellular carcinoma with radiofrequency ablation
- Impact of Splenectomy and Immunochemotherapy on Survival Following Gastrectomy for Carcinoma: Covariate Interaction with Immunosuppressive Acidic Protein, A Serum Marker for the Host Immune System
- Effectiveness of combination therapy of splenectomy and long-term interferon in patients with hepatitis C virus-related cirrhosis and thrombocytopenia
- Clinicopathological features, background liver disease, and survival analysis of HCV-positive patients with hepatocellular carcinoma : differences between young and elderly patients
- Changes in viral loads of lamivudine-resistant mutants during entecavir therapy
- Efficacy and anticarcinogenic activity of interferon for hepatitis C virus-related compensated cirrhosis in patients with genotype 1b low viral load or genotype 2
- Evaluation of long-term biochemical responses to combination therapy of interferon plus ribavirin in those infected with hepatitis C virus genotype 1b and high baseline viral load
- Efficacy of lamivudine therapy in elderly patients with chronic hepatitis B infection
- Type C-chronic hepatitis patients who had autoimmune phenomenon and developed jaundice during interferon therapy
- A randomized, double-blind, controlled trial of natural interferon-β therapy for e-antigen-negative chronic hepatitis B patients with abnormal transaminase levels
- Preoperative Endocrine Therapy for Clinical Stage A_2, B, and C Prostate Cancer: An Interim Report on Short-Term Effects
- Peak V^^・O_2 is More Potent Than B-Type Natriuretic Peptide as a Prognostic Parameter in Cardiac Patients
- Practical Risk Prediction Tools for Coronary Heart Disease in Mild to Moderate Hypercholesterolemia in Japan : Originated From the MEGA Study Data
- Overweight and obesity increase the risk for liver cancer in patients with liver cirrhosis and long-term oral supplementation with branched-chain amino acid granules inhibits liver carcinogenesis in heavier patients with liver cirrhosis
- High-dose interferon alpha-2b induction therapy in combination with ribavirin for Japanese patients infected with hepatitis C virus genotype 1b with a high baseline viral load
- Low rate of YMDD motif mutations in polymerase gene of hepatitis B virus in chronically infected patients not treated with lamivudine
- Usefulness of serum KL-6 for early diagnosis of idiopathic pulmonary fibrosis in patients with hepatitis C virus
- Model-fitting and Prediction of Bone Mineral Density in Postmenopausal Women Using an Exponential-type Nonlinear Mixed-effect Model
- Predictive values of amino acid sequences of the core and NS5A regions in antiviral therapy for hepatitis C : a Japanese multi-center study
- Early phase ll study of S-1, a new oral fluoropyrimidine, for advanced non-small-cell lung cancel
- Nucleotide sequences of hepatitis GB virus C. Identification of highly conserved domains in the 5' noncoding region and detection by polymerase chain reaction
- Repeated administration of recombinant human serum albumin caused no serious allergic reactions in patients with liver cirrhosis : a multicenter clinical study
- Therapeutic effects of stronger neo-minophagen C at different doses on chronic hepatitis and liver cirrhosis
- Involvement of GBV-C/HGV in liver diseases in Japan
- Clinical features of hepatitis B virus genotype A in Japanese patients
- Efficacy of prolonged interferon therapy for patients with chronic hepatitis C with HCV-genotype 1b and high virus load
- Components of Metabolic Syndrome and their Combinations as Predictors of Cardiovascular Disease in Japanese Patients with Type 2 Diabetes. Implications for Improved Definition. Analysis from Japan Diabetes Complications Study (JDCS)
- A Comparison of Low Versus Standard Dose Pravastatin Therapy for the Prevention of Cardiovascular Events in the Elderly : The Pravastatin Anti-atherosclerosis Trial in the Elderly(PATE)
- A Poisson Mixed Effects Model for Investigating the Exposure-by-Cohort Interaction : A Gibbs Sampling Approach
- Cilostazol Stroke Prevention Study : A Placebo-Controlled Double-Blind Trial for Secondary Prevention of Cerebral Infarction
- Randomized contolled clinical trial of lymphoblastoid interferon-α for chronic hepatitis C
- Incidence of the appearance of the red color sign on esophageal varices and its predictive factors : long-term observations of 359 patients with cirrhosis
- Twice-daily administration of interferon-beta for chronic hepatitis C is not superior to a once-daily regimen
- Interferon therapy for flare-up of hepatitis B virus infection after emergence of lamivudine-induced YMDD motif mutant
- Efficacy of IFN therapy based on duration period of negative HCV-RNA during IFN administration
- Distinction between chronic hepatitis and liver cirrhosis in patients with hepatitis C virus infection. Practical discriminant function using common laboratory data
- Progressive and sufficient decrease of hepatitis B core antibody can predict the disappearance of hepatitis B virus DNA in Japanese patients with hepatitis B surface antigen clearance
- Increased response rate to interferon therapy after a second course in hepatitis C patients who show relapse after the initial course
- Hepatic vascular side effects of styrene maleic acid neocarzinostatin in the treatment of hepatocellular carcinoma
- Fluctuation patterns of HCV-RNA serum level in patients with chronic hepatitis C
- A Device for Simultaneous Application of Sclerotherapy and Endoscopic Ligation for Management of Esophageal Varices
- Clinical and virological features of chronic hepatitis C carriers with normal alanine aminotransferase levels despite positive serum HCV-RNA after interferon therapy
- Enzyme-linked immunosorbent assay to detect hepatitis C virus serological groups 1 to 6
- Effect of arterial administration of a high-molecular weight antitumor agent, styrene maleic acid neocarzinostatin, in embolization-resistant liver cancer
- Predictive value of different hepatitis C serological assays in the treatment of chronic hepatitis C with interferon α
- Relationship of hepatocellular carcinogenesis with precore mutant virus and serum hepatitis B virus DNA concentration A longitudinal analysis of patients with cirrhosis
- Detection of Hantaviral Antibodies among Patients with Hepatitis of Unknown Etiology in Japan
- Efficacy of interferon therapy for aged patients with chronic hepatitis C
- Effect of arterial administration of a high molecular weight anti-tumor agent, styrene maleic acid neocarzinostatin, for multiple small liver cancer - A pilot study
- The Superiority of Laparoscopic Examination in Predicting Hepatocellular Carcinoma after Inteferon Therapy for Chronic Type C Hepatitis
- Hepatitis C virus subtype 3b infection in a hospital Japan: Epidemiological study
- Novel Hepatitis B variants in sibling carriers postitive for antibody to hepatitis B surface antigen
- Usefulness of HCV-RNA counts by the method of HCV-bDNA probe in interferon retreatment for patients with HCV-RNA positive chronic hepatitis C
- A Pilot Study of Thymosin α_1 Therapy for Chronic Hepatitis B Patients
- Significance of multicentric cancer recurrence after potentially curative ablation of hepatocellular carcinoma : a longterm cohort study of 892 patients with viral cirrhosis
- Randomized trial of prolonged interferon retreatment for chronic hepatitis C patients with HCV-genotype 1b and high virus load
- Serum levels of γ-globulin and total bilirubin influence the prevalence of multiple extrahepatic complication in patients with hepatitis C virus infection
- Randomized, controlled trial of natural interferon-α therapy for e-antigen-positive chronic hepatitis B patients
- Clinical characteristics of patients infected with hepatitis B virus genotypes A, B, and C
- Clinical Efficacy of Topical Nipradilol and Timolol on Visual Field Performance in Normal-Tension Glaucoma : A Multicenter, Randomized, Double-Masked Comparative Study
- A Case-Control Study of Risk Factors for Development of Type 2 Diabetes : Emphasis on Physical Activity
- Randomized trial of cyclophosphamide, epirubicin, and fluorouracil chemotherapy compared with cyclophosphamide, methotrexate, and fluorouracil with node-positive breast cancer in Japan
- Visual Field Loss in Patients with Normal-Tension Glaucoma Under Topical Nipradilol or Timolol : Subgroup and Subfield Analyses of the Nipradilol-Timolol Study
- Comprehensive geriatric assessment in elderly breast cancer patients
- Phase I/II and pharmacokinetic study of cladribine with 2-h infusion in Japanese patients with relapsed indolent B-cell lymphoma mostly pretreated with rituximab
- Mild Cognitive Impairment after Adjuvant Chemotherapy in Breast Cancer Patients - Evaluation of Appropriate Research Design and Methodology to Measure Symptoms
- Development of HCC in patients receiving adefovir dipivoxil for lamivudine-resistant hepatitis B virus mutants